While ineffective in significantly alleviating liver steatosis, treatment with CBD did reduce some of the markers of inflammation produced by the HFCD, including expression of TNFa and iNOS (Fig. 7), supporting CBD’s known anti-inflammatory activity. This evidence concerns the gene NOS2 and fatty liver disease.